Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG-PPD intradermal test in pulmonary tuberculosis patients
CTR20232242Phase 2Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bacillus calmette-guérin purified protein derivative in Tuberculosis (TB), pulmonary tuberculosis (TB), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Jul 2023; status: completed.
02
Drugs
bacillus calmette-guérin purified protein derivative
03
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20232242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232242.